150 related articles for article (PubMed ID: 32602121)
1. Localized immunoglobulin light chain amyloidosis: Novel insights including prognostic factors for local progression.
Basset M; Hummedah K; Kimmich C; Veelken K; Dittrich T; Brandelik S; Kreuter M; Hassel J; Bosch N; Stuhlmann-Laeisz C; Blank N; Müller-Tidow C; Röcken C; Hegenbart U; Schönland S
Am J Hematol; 2020 Oct; 95(10):1158-1169. PubMed ID: 32602121
[TBL] [Abstract][Full Text] [Related]
2. Light chain type predicts organ involvement and survival in AL amyloidosis patients receiving stem cell transplantation.
Sidiqi MH; Aljama MA; Muchtar E; Buadi FK; Warsame R; Lacy MQ; Dispenzieri A; Dingli D; Leung N; Gonsalves WI; Kumar SK; Kapoor P; Kourelis TV; Hogan WJ; Gertz MA
Blood Adv; 2018 Apr; 2(7):769-776. PubMed ID: 29615413
[TBL] [Abstract][Full Text] [Related]
3. Amyloidomas of the nervous system: a monoclonal B-cell disorder with monotypic amyloid light chain lambda amyloid production.
Laeng RH; Altermatt HJ; Scheithauer BW; Zimmermann DR
Cancer; 1998 Jan; 82(2):362-74. PubMed ID: 9445195
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic approach to and follow-up of difficult cases of AL amyloidosis.
Perfetti V; Garini P; Vignarelli MC; Marinone MG; Zorzoli I; Merlini G
Haematologica; 1995; 80(5):409-15. PubMed ID: 8566880
[TBL] [Abstract][Full Text] [Related]
5. AL amyloidosis with a localized B cell neoplasia.
Stuhlmann-Laeisz C; Schönland SO; Hegenbart U; Oschlies I; Baumgart JV; Krüger S; Röcken C
Virchows Arch; 2019 Mar; 474(3):353-363. PubMed ID: 30680453
[TBL] [Abstract][Full Text] [Related]
6. Serum immunoglobulin free light-chain measurement in primary amyloidosis: prognostic value and correlations with clinical features.
Kumar S; Dispenzieri A; Katzmann JA; Larson DR; Colby CL; Lacy MQ; Hayman SR; Buadi FK; Leung N; Zeldenrust SR; Ramirez-Alvarado M; Clark RJ; Kyle RA; Rajkumar SV; Gertz MA
Blood; 2010 Dec; 116(24):5126-9. PubMed ID: 20798235
[TBL] [Abstract][Full Text] [Related]
7. Nodular pulmonary amyloidosis is characterized by localized immunoglobulin deposition and is frequently associated with an indolent B-cell lymphoproliferative disorder.
Grogg KL; Aubry MC; Vrana JA; Theis JD; Dogan A
Am J Surg Pathol; 2013 Mar; 37(3):406-12. PubMed ID: 23282974
[TBL] [Abstract][Full Text] [Related]
8. A patient with AL amyloidosis with negative free light chain results.
Milani P; Valentini V; Ferraro G; Basset M; Russo F; Foli A; Palladini G; Merlini G
Clin Chem Lab Med; 2016 Jun; 54(6):1035-7. PubMed ID: 26677890
[TBL] [Abstract][Full Text] [Related]
9. The tropism of organ involvement in primary systemic amyloidosis: contributions of Ig V(L) germ line gene use and clonal plasma cell burden.
Comenzo RL; Zhang Y; Martinez C; Osman K; Herrera GA
Blood; 2001 Aug; 98(3):714-20. PubMed ID: 11468171
[TBL] [Abstract][Full Text] [Related]
10. [The role of PET-CT in decision making on the treatment of localized nodular form of pulmonary AL-amyloidosis].
Adam Z; Elleder M; Moulis M; Tichý M; Cervinková I; Rehák Z; Koukalová R; Fojtík Z; Hanke I; Pour L; Krejčí M; Zahradová L; Szturz P; Hájek R; Král Z; Mayer J
Vnitr Lek; 2012 Mar; 58(3):241-52. PubMed ID: 22486293
[TBL] [Abstract][Full Text] [Related]
11. Identification of amyloidogenic light chains requires the combination of serum-free light chain assay with immunofixation of serum and urine.
Palladini G; Russo P; Bosoni T; Verga L; Sarais G; Lavatelli F; Nuvolone M; Obici L; Casarini S; Donadei S; Albertini R; Righetti G; Marini M; Graziani MS; Melzi D'Eril GV; Moratti R; Merlini G
Clin Chem; 2009 Mar; 55(3):499-504. PubMed ID: 19131635
[TBL] [Abstract][Full Text] [Related]
12. Formation of immunoglobulin light chain amyloid oligomers in primary cutaneous nodular amyloidosis.
Clos AL; Lasagna-Reeves CA; Castillo-Carranza DL; Sengupta U; Jackson GR; Kelly B; Beachkofsky TM; Kayed R
Br J Dermatol; 2011 Dec; 165(6):1349-54. PubMed ID: 21729025
[TBL] [Abstract][Full Text] [Related]
13. Identification of clonal immunoglobulin λ light-chain gene rearrangements in AL amyloidosis using next-generation sequencing.
Kimura K; Tsukamoto S; Miyazaki K; Kawajiri-Manako C; Ishii A; Rahmutulla B; Fukuyo M; Oshima-Hasegawa N; Mitsukawa S; Takeda Y; Mimura N; Takeuchi M; Ohwada C; Iseki T; Matsusaka K; Sanada M; Yokote K; Kaneda A; Ishida T; Suzuki K; Nakaseko C; Sakaida E
Exp Hematol; 2021 Sep; 101-102():34-41.e4. PubMed ID: 34411686
[TBL] [Abstract][Full Text] [Related]
14. Lambda III subgroup immunoglobulin light chains are precursor proteins of nodular pulmonary amyloidosis.
Miura K; Shirasawa H
Am J Clin Pathol; 1993 Nov; 100(5):561-6. PubMed ID: 8249896
[TBL] [Abstract][Full Text] [Related]
15. Co-deposition of amyloidogenic immunoglobulin light and heavy chains in localized pulmonary amyloidosis.
Kaplan B; Martin BM; Boykov O; Gal R; Pras M; Shechtman I; Saute M; Kramer MR
Virchows Arch; 2005 Oct; 447(4):756-61. PubMed ID: 16021505
[TBL] [Abstract][Full Text] [Related]
16. The characteristics of patients with kidney light chain deposition disease concurrent with light chain amyloidosis.
Said SM; Best Rocha A; Valeri AM; Paueksakon P; Dasari S; Theis JD; Vrana JA; Obadina MO; Saghafi D; Alexander MP; Sethi S; Larsen CP; Joly F; Dispenzieri A; Bridoux F; Sirac C; Leung N; Fogo AB; McPhail ED; Nasr SH
Kidney Int; 2022 Jan; 101(1):152-163. PubMed ID: 34767832
[TBL] [Abstract][Full Text] [Related]
17. [Fibril-forming proteins: the amyloidosis. New hopes for a disease that cardiologists must know].
Arbustini E; Gavazzi A; Merlini G
Ital Heart J Suppl; 2002 Jun; 3(6):590-7. PubMed ID: 12116807
[TBL] [Abstract][Full Text] [Related]
18. Clonal immunoglobulin light chain variable region germline gene use in AL amyloidosis: association with dominant amyloid-related organ involvement and survival after stem cell transplantation.
Comenzo RL; Wally J; Kica G; Murray J; Ericsson T; Skinner M; Zhang Y
Br J Haematol; 1999 Sep; 106(3):744-51. PubMed ID: 10468868
[TBL] [Abstract][Full Text] [Related]
19. Al amyloidosis.
Desport E; Bridoux F; Sirac C; Delbes S; Bender S; Fernandez B; Quellard N; Lacombe C; Goujon JM; Lavergne D; Abraham J; Touchard G; Fermand JP; Jaccard A;
Orphanet J Rare Dis; 2012 Aug; 7():54. PubMed ID: 22909024
[TBL] [Abstract][Full Text] [Related]
20. Impact of light chain isotype on clinical features and outcomes in systemic AL amyloidosis.
Hopson MB; Bhutani D; Sarkaria S; Maurer MS; Griffin JM; Mapara M; Lentzsch S; Chakraborty R
Leuk Lymphoma; 2022 Sep; 63(9):2109-2113. PubMed ID: 35465769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
